At a glance
ClinicalIndex Comparison RecordN/ACompleted· 67 enrolled
Drug / intervention
Lehfilcon A toric contact lenses +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Clinical Performance of Two Monthly Replacement Toric Soft Contact Lenses
In Brief
A clinical study evaluating Lehfilcon A toric contact lenses, Comfilcon A toric contact lenses, and 1 other intervention for Ametropia and Astigmatism. Completed, enrolled 67 participants across 5 sites.
Detailed Summary
The purpose of this study is to assess the clinical performance of TOTAL30 for Astigmatism (T30fA) soft contact lenses with Biofinity Toric soft contact lenses.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmetropia, Astigmatism
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedDec 2023
Enrollment StartJan 2024
Primary CompletionMay 2024
TodayJul 2026
First PostedDec 11, 2023
Enrollment StartJan 23, 2024
Primary CompletionMay 12, 2024
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 2.6 years ago
Interventions
Lehfilcon A toric contact lensesdevice
Commercially available soft contact lenses worn as indicated
Comfilcon A toric contact lensesdevice
Commercially available soft contact lenses) worn as indicated
CLEAR CAREdevice
Commercially available hydrogen peroxide-based solution for daily cleaning and disinfection of contact lenses used as indicated